#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fallopian tube cancer Adenocarcinoma gastric Subdural haematoma Head and neck cancer Stress cardiomyopathy Dementia Alzheimer's type Human papilloma virus immunisation Activated PI3 kinase delta syndrome Alveolar proteinosis Carcinoid tumour Obesity Glycogen storage disease type I Staphylococcal infection Pancreatic carcinoma metastatic Leber's congenital amaurosis More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Diagnostics Netherton’s syndrome – Basic Information Small intestine leiomyosarcoma Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Ewing’s sarcoma – Basic Information Hereditary neuropathic amyloidosis – Trials in Disease Angiosarcoma non-metastatic – Basic Information Thrombotic thrombocytopenic purpura – Basic Information Kearns-Sayre syndrome – Treatment Marginal zone lymphoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TTX-381 Pp1815 Venglustat Soft Paraffin And Fat Products Lu Ag09222 4-Hydroxy-N-Desmethyltamoxifen Izaflortaucipir (18F) VOROLANIB 177LU-FAP-2286 Inavolisib XELAFASLATIDE Sirexatamab Magnesium Oxybate Taminadenant Glimepiride RNMB1 Sibeprenlimab Damoctocog Alfa Pegol Imatinib Regorafenib More therapies…

    Learn about Your Condition

    Hypersensitivity Epstein-Barr virus infection Food allergy Triple positive breast cancer Essential thrombocythaemia Autoimmune disorder Corneal dystrophy Macular degeneration Radiation skin injury Astrocytoma malignant Cluster headache Oropharyngeal cancer Bacterial vaginosis Papillary thyroid cancer Atrial septal defect More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on Early Measles Immunization with MMR-0 Vaccine for Infants Under 12 Months During a Measles Outbreak

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Measles Virus Edmonston-Enders Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • Mumps Virus Jeryl Lynn (Level B) Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
    The Netherlands

  • Study on Immune Response to Intradermal Ixiaro Vaccine in Healthy Adults Aged 18-64

    Not yet recruiting

    3 1 1 1
    Finland

  • Study on the Safety and Immune Response of rBCG-N-RSV Vaccine Compared to BCG Vaccine in Adults Over 60 with Respiratory Syncytial Virus (RSV) Concerns

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Greece

  • Study on the Immune Response and Safety of a Second Dose of Investigational Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Varicella
    Investigated Drugs:
    • VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED)
    • GSKVX000000025896
    • VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS
    Denmark Norway

  • Study on Immune Response and Safety of Measles, Mumps, Rubella, and Varicella Vaccine in Healthy Children Aged 4 to 6 Years

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Measles Virus Edmonston-Enders Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • Mumps Virus Jeryl Lynn (Level B) Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED)
    Latvia Spain

  • Study on the Effectiveness of Elixirium Thymi Compositum for Treating Acute Bronchitis in Children

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bronchitis
    Investigated Drugs:
    • LIQUID EXTRACT OF THYME (1:3.45-3.85), EXTRACTION SOLVENT: ETHANOL 27%(V/V)
    Hungary
Previous Page
1 … 18 19 20 21 22 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!